Premium
UCP3 in muscle wasting, a role in modulating lipotoxicity?
Author(s) -
Minnaard Ronnie,
Schrauwen Patrick,
Schaart Gert,
Hesselink Matthijs K.C.
Publication year - 2006
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/j.febslet.2006.08.066
Subject(s) - lipotoxicity , ucp3 , medicine , endocrinology , oxidative stress , wasting , chemistry , biology , uncoupling protein , adipose tissue , insulin resistance , insulin , brown adipose tissue
UCP3 has been postulated to function in the defense against lipid‐induced oxidative muscle damage (lipotoxicity). We explored this hypothesis during cachexia in rats (zymosan‐induced sepsis), a condition characterized by increased oxidative stress and supply of fatty acids to the muscle. Muscle UCP3 protein content was increased 2, 6 and 11 days after zymosan injection. Plasma FFA levels were increased at day 2, but dropped below control levels on days 6 and 11. Muscular levels of the lipid peroxidation byproduct 4‐hydroxy‐2‐nonenal (4‐HNE) were increased at days 6 and 11 in zymosan‐treated rats, supporting a role for UCP3 in modulating lipotoxicity during cachexia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom